CytoAgents Receives NIH Funding to Accelerate Treatment for Cytokine Storm

XCOR’s aim is for daily space flights. Watch this interview with XCOR founder Jeff Greason. Watch now >> read more

A new solution has been put forward to Michael-Gagne, now, through technology called eSight glasses — electronic glasses for the... read more

Myomo, Inc., a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC... read more

Boston is a city of legendary talent. Beantown’s sport legacies, etched along its historic streets, whisper the names of athletes... read more

CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it... read more

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that... read more

Boston-based cloud service company, Wasabi recently announced the opening of its first European data centre based in Amsterdam. Read more... read more

DetraPel, the advanced materials company that manufactures sustainable coatings announced the completion of its $7.6M Series A funding led by... read more

India will soon start clinical trials of US-based Akston Biosciences second-generation Covid-19 vaccine — one of the most promising candidates... read more